Vitality Watch

Dossier pubmed observational 18-aug-2026
Human cohort, case-control, or epidemiological association

Circulating biomarkers and polygenic scores for cardiovascular risk prediction in healthy older adults: differential and complementary contributions.

Key claim: In healthy adults aged ≥70 without prior CVD, circulating biomarkers (hsCRP, NT-proBNP, hsTnI) and polygenic scores add complementary value for MACE prediction beyond traditional risk factors, with biomarkers improving discrimination more and PGSs contributing relatively more to case identification.

Abstract

BACKGROUND AND AIMS: Atherothrombotic cardiovascular disease (CVD) risk prediction in older adults remains suboptimal. The relative contributions of circulating protein biomarkers and polygenic scores (PGS) are uncertain. METHODS: In 10,433 older individuals aged ≥70 years without prior CVD events, we evaluated traditional risk factors alongside three circulating biomarkers (high-sensitivity C-reactive protein, hsCRP; N-terminal pro-b-type natriuretic peptide, NT proBNP; and high-sensitivity troponin I, hsTnI), and two PGSs (coronary artery disease, ischemic stroke) for prediction of major adverse cardiovascular events (MACE). Associations were assessed using Cox proportional hazards models. Model performance was evaluated using the C-index, calibration, and continuous net reclassification improvement (NRI). RESULTS: Over a median follow-up of 4.5 years (interquartile range 3.4-5.5), 359 MACE occurred. Each biomarker and both PGSs were independently associated with MACE, with NT-proBNP showing the strongest association (adjusted HR per SD 1.50, 95% CI 1.36-1.65). Compared with the base clinical model, the addition of the three circulating biomarkers (hsCRP, NT-proBNP, and hsTnI) resulted in a greater improvement in discrimination than the addition of the two PGSs (ΔC-index +0.041 vs. +0.016). The fully combined model achieved the highest discrimination (C-index 0.734) with good calibration. Circulating biomarkers improved reclassification primarily through correct identification of non-cases (NRI 0.34), whereas PGSs contributed relatively more to identification of cases (NRI 0.31). CONCLUSIONS: In older adults, circulating biomarkers and PGSs provide cumulative information for CVD risk prediction, contributing differently to discrimination and risk reclassification. Integrating biomarkers and genetic risk may improve CVD risk prediction in older people beyond traditional risk factors.

Why this matters

Risk stratification in healthy adults over 70 is where traditional calculators lose resolution, and the field has argued over whether to layer on bloods, genomics, both, or neither. This analysis pins down that in a healthy ≥70 cohort the two layers aren’t redundant: biomarkers push discrimination harder, polygenic scores catch cases the discrimination metric understates, and the combined model modestly outperforms either alone. It is incremental refinement of the measurement layer older-adult CVD prevention trials rely on, not a paradigm shift.

Source

Link

Briefing card

Circulating biomarkers and polygenic scores for cardiovascular risk prediction in healthy older adults: differential and complementary contributions.
Stage: observational · pubmed · 18-aug-2026

If you are over 70 with no cardiovascular disease history, this cohort found that adding hsCRP, NT-proBNP, and hsTnI to your risk assessment sharpens MACE prediction more than a CVD polygenic score, while the polygenic score adds a different kind of signal by flagging cases the biomarkers miss.

In healthy adults aged ≥70 without prior CVD, circulating biomarkers (hsCRP, NT-proBNP, hsTnI) and polygenic scores add complementary value for MACE prediction beyond traditional risk factors, with biomarkers improving discrimination more and PGSs contributing relatively more to case identification.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.atherosclerosis.2026.121881

build build 880 · 2bcef25 · 2026-11-18